Latest Articles in revenue
Fortis Q1 FY24 Results: PAT dipped 8.8% YoY, Rev Up 11.4 % On Yearly Basis
Operating margins stood at 15.2 per cent for the quarter versus 16.2 per cent in Q1 FY23 impacted in part due to a lower occupancy and a less than favorable payor mix
Read More
AstraZeneca Beat Expectations For Q1 Profit & Revenue
Analysts on average were expecting USD 1.71 per share on sales of about USD 10.6 billion, according to company-compiled consensus estimates. AstraZeneca's performance in emerging markets was particularly strong, CEO Pascal Soriot said in a statement.
Read More
Revenue Of Indian Hospitals To Grow By 10-11% In FY23-24: Report
Revenues of private hospitals are set to grow 10-11 per cent in fiscals 2023 and 2024 on the back of healthy bed occupancy and sustenance of high average revenue per occupied bed (ARPOB), supported by increasing domestic demand and pick-up in medical tourism, market intelligence and data analytics f
Read More
Pfizer's Annual Revenue To Touch $10 Bn-$15 Bn Sourced From mRNA Vaccines By 2030
The company's revenue is expected to top $100 billion this year- more than double the pre-pandemic level - helped by strong demand for its COVID-19 vaccine and oral treatment Paxlovid
Read More
Dr Reddy's Q2 PAT Rises 12 % YoY To 1,113 Cr
The company also marked a 9 per cent increase in consolidated revenue at Rs 6,306 crore as against revenue of Rs 5,763 crore in the year-ago period
Read More
Syngene Intl Q2 PAT Rises 11% YoY To Rs 102 Cr
Its revenue also grew 26 per cent YoY to Rs 768 crore in the quarter under review
Read More
Jan Aushadhi Outlets Reach Over Rs 100 Cr Revenue In May
Pharmaceuticals & Medical Devices Bureau of India (PMBI) is the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)."In its journey of last eight years, starting from the annual turnover of Rs 8 crore in year 2014-15, PMBI has clocked its highest monthly sales turnover of R
Read More
Centre For Sight Unveils Plans For CFS Vision With 500 Centres
CFS Vision targets to achieve annual revenue of Rs 350 crore by 2027 and plans an outlay of Rs 250 crore over the next five years.
Read More
HealthCare Global Enterprises Reports Q2 FY22 Results
"The growth in revenue has also been matched by corresponding growth in profitability margins. We closed the second quarter with our highest ever EBITDA at Rs. 65 crore with 1.6 per cent margin expansion over the previous quarter."
Read More
Wockhardt’s Q2 FY22 Revenue Grew By 21% Over Q2 FY21
The Company recorded substantial growth in Revenue (up by 21 per cent over previous corresponding quarter) and in EBITDA at Rs 109 crore compared to a nominal profit of Rs 27 crore in the corresponding quarter of the previous year.
Read More